Evidence map›Paper›PMID 21954225›Full record

ArticleEnvironmental health perspectives2012

Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.

Zhishan Wang, Junling Yang, Theresa Fisher, Hua Xiao, Yiguo Jiang, Chengfeng Yang

Open access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Epigenetic downregulation of OEnvironmental pollution (Barking, Essex : 1987) · 2024
    Article
  3. Article
  4. Arsenic and cancer: Evidence and mechanisms.Advances in pharmacology (San Diego, Calif.) · 2023
    Article
  5. Article
  6. Review
  7. Chronic and acute arsenic exposure enhance EGFR expression via distinct molecular mechanisms.Toxicology in vitro : an international journal published in association with BIBRA · 2020
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Persistent Exposure toFrontiers in cellular and infection microbiology · 2017
    Article
  18. The role of microRNAs in metal carcinogen-induced cell malignant transformation and tumorigenesis.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2016
    Review
  19. 17β-Estradiol Inhibites Tumor Necrosis Factor-α Induced Apoptosis of Human Nucleus Pulposus Cells via the PI3K/Akt Pathway.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Zhishan WangDepartment of Physiology, Michigan State University, East Lansing, MI 48824, USA.
Junling Yang
Theresa Fisher
Hua Xiao
Yiguo Jiang
Chengfeng Yang
Michigan State University · USState Key Laboratory of Respiratory Disease · CN

Funding

The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAsR01ES017777 · NIEHS · MICHIGAN STATE UNIVERSITY · PI YANG, CHENGFENG · 2010 to 2014
$1.7M
NIEHS NIH HHS 1R01ES017777-01A1NIEHS NIH HHS R01 ES017777
6 · The paper itself

Abstract

backgroundArsenic is one of the most common environmental contaminants. Long-term exposure to arsenic causes human bronchial epithelial cell (HBEC) malignant transformation and lung cancer. However, the mechanism of arsenic lung carcinogenesis is not clear, and the migratory and invasive properties of arsenic-transformed cells (As-transformed cells) have rarely been studied.

objectivesThis study was designed to investigate the migratory and invasive behavior of As-transformed HBECs and the underlying mechanism.

methodsAs-transformed p53lowHBECs were generated by exposing p53-knockdown HBECs to sodium arsenite (2.5 μM) for 16 weeks. Cell migration was assessed by transwell migration and wound-healing assay. Cell invasion was evaluated using Matrigel-coated transwell chambers. Gene overexpression, small interfering RNA (siRNA) knockdowns, and pharmacological inhibitors were used to determine the potential mechanism responsible for enhanced cell migration and invasion.

resultsTranswell migration and invasion assays revealed that As-transformed p53lowHBECs were highly migratory and invasive. Akt (also known as protein kinase B) and extracellular signal-regulated protein kinase 1/2 (Erk1/2) were strongly activated in As-transformed p53lowHBECs. Stable expression of microRNA 200b in As-transformed p53lowHBECs abolished Akt and Erk1/2 activation and completely suppressed cell migration and invasion. Pharmacological inactivation of Akt but not Erk1/2 significantly decreased cell migration and invasion. Inhibition of Akt reduced the expression of epithelial-to-mesenchymal transition-inducing transcription factors zinc-finger E-box-binding homeobox factor 1 (ZEB1) and ZEB2. siRNA knockdown of ZEB1 and ZEB2 impaired As-transformed p53lowHBEC migration and invasion.

conclusionsAkt activation plays a critical role in enabling As-transformed HBEC migration and invasion by promoting ZEB1 and ZEB2 expression.

Indexed as

ArsenicBronchiCell LineCell MovementCell Transformation, NeoplasticEpithelial CellsHomeodomain ProteinsHumansNeoplasm InvasivenessProto-Oncogene Proteins c-aktRepressor ProteinsRespiratory MucosaTranscriptional ActivationTranscription FactorsZinc Finger E-box-Binding Homeobox 1Zinc Finger E-box Binding Homeobox 2ArsenicHomeodomain ProteinsProto-Oncogene Proteins c-aktRepressor ProteinsTranscription FactorsZEB1 protein, humanZEB2 protein, humanZinc Finger E-box-Binding Homeobox 1Zinc Finger E-box Binding Homeobox 2

Identifiers

PMID21954225
PMCPMC3261952
OpenAlexW2090859265

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.